← Eichor
Condition: Conjunctivitis Allergic Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Conjunctivitis Allergic

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

An Efficacy and Safety Study of Cenegermin Ophthalmic Solution Compared With Vehicle in the Treatment of PCED
Phase 3 · 77 location(s) · Dompé Farmaceutici S.p.A · NCT07519902Treatment of Ocular Surface Inflammations
Phase N/A · 1 location(s) · Semmelweis University · NCT07732855A Study to Compare the Effectiveness and Safety of T1695 Versus Ciclosporin in Participants With Moderate to Severe Vern
Phase 2 · 11 location(s) · Laboratoires Thea · NCT07169695Study of Bet v1 Antibodies Effect on Eye Allergy Symptoms in Adolescents and Adults With Birch Pollen Allergy
Phase 3 · 2 location(s) · Regeneron Pharmaceuticals · NCT07309432Kelulut Honey for Allergic Conjunctivitis and Dry Eye Symptoms
NA · 1 location(s) · Universiti Sains Malaysia · NCT07273747Evaluation of TL-925 for the Treatment of Allergic Conjunctivitis
Phase 2 · 1 location(s) · Telios Pharma, Inc. · NCT06686472Proteomic and Metabolomic Lacrimal Fingerprint in Diverse Pathologies of the Ocular Surface
Phase N/A · 2 location(s) · Centre hospitalier de l'Université de Montréal (CHUM) · NCT041987403% Diquafosol Ophthalmic Solution for Active Moderate-to-Severe Vernal Keratoconjunctivitis
Phase 3 · 1 location(s) · The University of Hong Kong · NCT06903884Evaluation of TL-925 for the Treatment of Seasonal Allergic Conjunctivitis
Phase 2 · 1 location(s) · Telios Pharma, Inc. · NCT07220408
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.